ResearchWho?

범승훈

Clinical Associate Professor

연세대학교(신촌) 의과대학 의학과

논문[65]

#65. First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors

2022.10 · Investigational New Drugs 40(1)

(DOI) https://doi.org/10.1007/s10637-022-01277-9

#64. Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea

2022.9 · Journal of Cancer 13(13):3396-3403

(DOI) https://doi.org/10.7150/jca.74107